Their reply is vague. No measures have been undertaken yet. But they are running out of time. 400k won't bring them through the March-quarter. So no good Partner for CM8
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
AXN Rising demand, China's 'tech war' bans leaves this germanium explorer with significant investment potential